BANDARAM
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Events:
Dividend
Dividend
Rights
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Bandaram Pharma Pack do?
Bandaram Pharma Packtech Limited, formerly known as Shiva Medicare Limited, is an Indian company incorporated in 1993. It is engaged in the trading of paper.
Who are the competitors of Bandaram Pharma Pack?
Bandaram Pharma Pack major competitors are Shelter Pharma, Walpar Nutritions, Medicamen Organics, Chandra Bhagat Pharm, Roopa Industries, Shanmuga Hospital, Deccan Health Care. Market Cap of Bandaram Pharma Pack is ₹46 Crs. While the median market cap of its peers are ₹49 Crs.
Is Bandaram Pharma Pack financially stable compared to its competitors?
Bandaram Pharma Pack seems to be less financially stable compared to its competitors. Altman Z score of Bandaram Pharma Pack is 3.15 and is ranked 5 out of its 8 competitors.
Does Bandaram Pharma Pack pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Bandaram Pharma Pack latest dividend payout ratio is 23.02% and 3yr average dividend payout ratio is 17.33%
How has Bandaram Pharma Pack allocated its funds?
Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable
How strong is Bandaram Pharma Pack balance sheet?
Balance sheet of Bandaram Pharma Pack is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Bandaram Pharma Pack improving?
Yes, profit is increasing. The profit of Bandaram Pharma Pack is ₹0.52 Crs for Mar 2024, ₹0.26 Crs for Mar 2023 and -₹0.01 Crs for Mar 2022
Is the debt of Bandaram Pharma Pack increasing or decreasing?
Yes, The net debt of Bandaram Pharma Pack is increasing. Latest net debt of Bandaram Pharma Pack is ₹17.04 Crs as of Mar-25. This is greater than Mar-24 when it was ₹12.62 Crs.
Is Bandaram Pharma Pack stock expensive?
Bandaram Pharma Pack is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Bandaram Pharma Pack is 45.86, while 3 year average PE is 64.26. Also latest EV/EBITDA of Bandaram Pharma Pack is 30.44 while 3yr average is 24.38.
Has the share price of Bandaram Pharma Pack grown faster than its competition?
Bandaram Pharma Pack has given better returns compared to its competitors. Bandaram Pharma Pack has grown at ~6.3% over the last 1yrs while peers have grown at a median rate of -19.0%
Is the promoter bullish about Bandaram Pharma Pack?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Bandaram Pharma Pack is 75.0% and last quarter promoter holding is 75.0%.
Are mutual funds buying/selling Bandaram Pharma Pack?
There is Insufficient data to gauge this.